Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted nonviral gene therapy in prostate cancer
Najla Altwaijry, Sukrut Somani, Christine Dufès
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 5753-5767
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

In vivo gene delivery mediated by non-viral vectors for cancer therapy
Reza Mohammadinejad, Ali Dehshahri, Vijay Sagar Madamsetty, et al.
Journal of Controlled Release (2020) Vol. 325, pp. 249-275
Open Access | Times Cited: 201
Biodegradable Polymers for Gene Delivery
Thresia Thomas, Heidar‐Ali Tajmir‐Riahi, C. K. S. Pillai
Molecules (2019) Vol. 24, Iss. 20, pp. 3744-3744
Open Access | Times Cited: 126
ZIF-C for targeted RNA interference and CRISPR/Cas9 based gene editing in prostate cancer
Arpita Poddar, Suneela Pyreddy, Francesco Carraro, et al.
Chemical Communications (2020) Vol. 56, Iss. 98, pp. 15406-15409
Open Access | Times Cited: 50
Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota
Lin Chen, Yuxin Xu, Yuanshuo Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina
Tien‐Chun Yang, Chia-Yu Chang, Aliaksandr A. Yarmishyn, et al.
Acta Biomaterialia (2019) Vol. 101, pp. 484-494
Open Access | Times Cited: 53
Clinical translation of gene medicine
Fazhan Wang, Zhou Qin, Hansi Lu, et al.
The Journal of Gene Medicine (2019) Vol. 21, Iss. 7
Open Access | Times Cited: 49
Biomaterial-assisted scalable cell production for cell therapy
Ruoyu Chen, Ling Li, Lu Feng, et al.
Biomaterials (2019) Vol. 230, pp. 119627-119627
Closed Access | Times Cited: 44
Adrinogenic Colon Cancer Treatment Using Poly (β-Amino Esters) (PBAEs): Mechanistic Insights, Advanced Utilization Approaches, and Future Directions
Shridhar Thorat, Sankha Bhattacharya
Journal of Macromolecular Science Part B (2025), pp. 1-17
Closed Access
OTUB1 Promotes Progression and Proliferation of Prostate Cancer via Deubiquitinating and Stabling Cyclin E1
Yihao Liao, Ning Wu, Keke Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 26
Hydrogels in Gene Delivery Techniques for Regenerative Medicine and Tissue Engineering
Kexing Xu, Qinmeng Zhang, Danji Zhu, et al.
Macromolecular Bioscience (2024) Vol. 24, Iss. 6
Closed Access | Times Cited: 3
Development and Characterization of High Efficacy Cell-Penetrating Peptide via Modulation of the Histidine and Arginine Ratio for Gene Therapy
Yu Liu, Huan-Huan Wan, Duo-Mei Tian, et al.
Materials (2021) Vol. 14, Iss. 16, pp. 4674-4674
Open Access | Times Cited: 23
Novel Strategies for Targeting Prostate Cancer
Pritish Kumar Panda, Shivani Saraf, Ankita Tiwari, et al.
Current Drug Delivery (2019) Vol. 16, Iss. 8, pp. 712-727
Closed Access | Times Cited: 24
A non-viral nano-delivery system targeting epigenetic methyltransferase EZH2 for precise acute myeloid leukemia therapy
Babita Kaundal, Avinash Chandra Kushwaha, Anup K. Srivastava, et al.
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 37, pp. 8658-8670
Closed Access | Times Cited: 20
Lactoferrin-Bearing Gold Nanocages for Gene Delivery in Prostate Cancer Cells in vitro
Jamal Almowalad, Sukrut Somani, Partha Laskar, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4391-4407
Open Access | Times Cited: 17
Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions
Konatham Teja Kumar Reddy, Karthickeyan Krishnan, P. Shanmugasundaram, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 6, pp. 830-845
Open Access | Times Cited: 2
Progress in gene therapy treatments for prostate cancer
Jingxin Xue, Keming Chen, Heyi Hu, et al.
Biotechnology and Applied Biochemistry (2021) Vol. 69, Iss. 3, pp. 1166-1175
Closed Access | Times Cited: 15
miR‑1303 promotes the proliferation, migration and invasion of prostate cancer cells through regulating the Wnt/β‑catenin pathway by targeting DKK3
Бо Лю, Weidong Zhou, Huiyang Jiang, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 15
MicroRNA‐140 inhibit prostate cancer cell invasion and migration by targeting YES proto‐oncogene 1
Shijia Zhao, Chuanling Jie, Pengchao Xu, et al.
Journal of Cellular Biochemistry (2019) Vol. 121, Iss. 1, pp. 482-488
Closed Access | Times Cited: 11
Polymer-peptide ternary systems as a tool to improve the properties of plasmid DNA vectors in gene delivery
Tânia Albuquerque, Rúben Faria, Ângela Sousa, et al.
Journal of Molecular Liquids (2020) Vol. 309, pp. 113157-113157
Closed Access | Times Cited: 9
Mechanism of WASP and WAVE family proteins in the progression of prostate cancer
Mohd Mughees, Faizia Bano, Saima Wajid
PROTOPLASMA (2021) Vol. 258, Iss. 4, pp. 683-693
Closed Access | Times Cited: 9
REX-1 Represses RASSF1a and Activates the MEK/ERK Pathway to Promote Tumorigenesis in Prostate Cancer
Weijing Liu, An Xie, Chunhua Tu, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 10, pp. 1666-1675
Open Access | Times Cited: 9
Dual ATP/reduction-responsive polyplex to achieve the co-delivery of doxorubicin and miR-23b for the cancer treatment
Xiuhui Tang, Xiao Liang, Kai Wen, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 206, pp. 111955-111955
Closed Access | Times Cited: 8
Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis
Dong Zhang, Xiaojie Yang, Qidong Luo, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 7, pp. 1001-1011
Closed Access | Times Cited: 8
The Comprehensive Analysis of Hub Gene ARRB2 in Prostate Cancer
Bing Zhou, Hong Song, Wuqin Xu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 6
<p>PSMA-Targeting Reduction-Cleavable Hyperbranched Polyamide-Amine Gene Delivery System to Treat the Bone Metastases of Prostate Cancer</p>
Yongheng Ye, Lingli Zhang, Yuhu Dai, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 7173-7184
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top